340B Drug Pricing Program

Guidance to 340B providers in Puerto Rico

Public Health Emergency Declaration by the Secretary

We recognize that circumstances surrounding disaster relief efforts warrant flexibility for entities eligible for participation in the 340B Program.

Therefore, eligible entities in Puerto Rico may immediately enroll for the 340B Program during the Public Health Emergency Declaration by the Secretary, rather than having to wait for the normal quarterly registration period.

We believe this will enable these entities to meet the needs of the residents affected by this disaster.

Contact: If you are in the listed states/territories and would like to enroll, email the 340B Prime Vendor Program or call 1-888-340-2787.

The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.

Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices.

Eligible health care organizations/covered entities are defined in statute and include HRSA-supported health centers and look-alikes, Ryan White clinics and State AIDS Drug Assistance programs, Medicare/Medicaid Disproportionate Share Hospitals, children’s hospitals, and other safety net providers. See the full list of eligible organizations/covered entities.

To participate in the 340B Program, eligible organizations/covered entities must register and be enrolled with the 340B program and comply with all 340B Program requirements. Once enrolled, covered entities are assigned a 340B identification number that vendors verify before allowing an organization to purchase 340B discounted drugs.

Apexus LLC Awarded the 340B Prime Vendor Agreement

The Health Resources and Services Administration (HRSA) has awarded the 340B Prime Vendor Agreement to Apexus LLC after a competitive bid process.

The 340B Prime Vendor will continue to support the distribution of covered outpatient drugs through the 340B Drug Pricing Program and as a resource to 340B stakeholders.

Get more information and technical assistance via the 340B Prime Vendor Program HRSA Exit Disclaimer.

Date Last Reviewed:  January 2020